← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #573 OF 1,000 MOST-CITED

Human food by-products

FDA cited this observation 32 times across 31 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods32
BY FISCAL YEAR
FY20262
FY20254
FY20242
FY20233
FY20227
FY20213
FY20204
FY20194
FY20183

How FDA worded it — real examples

You did not hold a human food by-product intended for distribution as animal food under conditions that will protect against contamination.

Hans Bakery, Inc. dba Andersen's Bakery · Hayward, California · Foods · 2026-03-17

You did not hold a human food by-product intended for distribution as animal food under conditions that will protect against contamination.

JSL Foods, Inc. · Commerce, California · Foods · 2025-10-29

You did not hold a human food by-product intended for distribution as animal food under conditions that will protect against contamination.

Ocean Group Inc · Las Vegas, Nevada · Foods · 2025-09-12

You did not hold a human food by-product intended for distribution as animal food under conditions that will protect against contamination.

Alpha Baking Company, Inc. · Chicago, Illinois · Foods · 2025-05-23

You did not hold a human food by-product intended for distribution as animal food under conditions that will protect against contamination.

Taqueria Y Tortilleria Lupita · Oklahoma City, Oklahoma · Foods · 2025-05-22

You did not hold a human food by-product intended for distribution as animal food under conditions that will protect against contamination.

Oakhurst Industries Inc. (DBA Freund Baking Company, Inc.) · Commerce, California · Foods · 2025-02-28

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →